Jump to content
Join Talk Chelsea and join in with the discussions! Click Here


Followers 3

Recommended Posts

13 minutes ago, Laylabelle said:

Getting me first one Friday and the next end of August..trying to find a centre was fun! Didn't fancy the many miles journey to some funky location lol. 

Do feel for the City fans who travelled..saw that loss and been now told to isolate. Least the Chelsea lot had a happy journey back before the news..still a faff

Can we be over this now

end of August? surely you mean end of June for the 2nd one.

Pfizer is 21 days apart.

Moderna 28 days apart.

Link to post
Share on other sites
  • Replies 972
  • Created
  • Last Reply

Top Posters In This Topic

Top Posters In This Topic

Popular Posts

Guys, i just want to say, take care of yourselves and your families during this horrible pandemic, stay safe always and God bless you all. Hug 🙏💪👊

In the US people queue up to buy guns. In the Netherlands thousands of people were today queueing to buy weed before all coffee shops (and restaurants, cafes etc.) closed down at 6pm and will remain s

Good article - history shows governments are really slow to withdraw big brother state apparatus and surveillance when emergencies are over. Theyre also quite keen for everyone to have the Covid

Posted Images

For anyone having trouble finding a vaccination centre near to them,  they should phone their doctors surgery who will probably be able to find one closer  than what's on the gov.uk site. 

My doctor's booked me one a 5 mins drive away, while the nearest one on gov.uk was 6 miles.

Very efficiently run centre and in and out in five mins.

Link to post
Share on other sites
Posted (edited)
3 hours ago, Vesper said:

end of August? surely you mean end of June for the 2nd one.

Pfizer is 21 days apart.

Moderna 28 days apart.

Nope def end of August..up to 12 weeks apart for whatever one it ends up being.

Edited by Laylabelle
Link to post
Share on other sites
5 hours ago, Laylabelle said:

Nope def end of August..up to 12 weeks apart for whatever one it ends up being.

you really need to look into that

that is completely against the dosing schedule and quite likely puts you at further risk

Link to post
Share on other sites
1 hour ago, Vesper said:

you really need to look into that

that is completely against the dosing schedule and quite likely puts you at further risk

UK guidance..wherever its the same elsewhere.. guess not lol. 

8 weeks for over 50s.. 12 weeks for everyone else...

Link to post
Share on other sites
Posted (edited)
7 minutes ago, Laylabelle said:

UK guidance..wherever its the same elsewhere.. guess not lol. 

8 weeks for over 50s.. 12 weeks for everyone else...

unless that is some different vax, that literally is unlikely anywhere else I have seen for the Pfizer and Moderna

I do not even count the AstraZeneca vax, as it is worthless against the SA variant and likely Delta too

Edited by Vesper
Link to post
Share on other sites
hace 10 horas, Vesper dijo:

end of August? surely you mean end of June for the 2nd one.

Pfizer is 21 days apart.

Moderna 28 days apart.

They say its sometime after at least 21 days that you can get it but can be up to 12 weeks maximum before you get the second dose. Or thats what they said that at the centre to me but I am 25, so I suppose to have got the first one on Thursday, in June, thats a lot quicker than I expected.

I was expecting maybe end of next month or start of August. Ideally it wont take as long as 12 weeks to get round 2 but I know older relatives and friends of friends who had to wait say at least 8 or 9 weeks to get the second round. My dad is still waiting for his second also and he’s in his mid 50s but hes had work commitments that haven’t helped either.

Either way if theres anyone on here who’s not got the first dose already and is nervous about the vaccine or the procedure, don’t be! The only side effect if you want to call it that from Thursday was that I had a wee bit of a sore arm at the bit where they injected it. They inject it into a specific muscle in your upper arm and it literally takes 5 seconds then you sit and chill out for 10-15 minutes in the centre to ensure you feel ok and are free to go.

Link to post
Share on other sites
8 hours ago, OneMoSalah said:

They say its sometime after at least 21 days that you can get it but can be up to 12 weeks maximum before you get the second dose. Or thats what they said that at the centre to me but I am 25, so I suppose to have got the first one on Thursday, in June, thats a lot quicker than I expected.

I was expecting maybe end of next month or start of August. Ideally it wont take as long as 12 weeks to get round 2 but I know older relatives and friends of friends who had to wait say at least 8 or 9 weeks to get the second round. My dad is still waiting for his second also and he’s in his mid 50s but hes had work commitments that haven’t helped either.

Either way if theres anyone on here who’s not got the first dose already and is nervous about the vaccine or the procedure, don’t be! The only side effect if you want to call it that from Thursday was that I had a wee bit of a sore arm at the bit where they injected it. They inject it into a specific muscle in your upper arm and it literally takes 5 seconds then you sit and chill out for 10-15 minutes in the centre to ensure you feel ok and are free to go.

I haven't heard of anyone being offered their second jab as early as 21 days after the first, or close to that. The average time is 8 weeks though I gather they're trying to speed it up to 6 weeks.

The only side effects I had were a bit of a headache, temperature and tiredness for a few hours.

Also, seeing that I got a lift and wasn't driving,  they let me leave straight away. 


  • Like 1
Link to post
Share on other sites

Probably depends where you are as well. Some places can probably offer it closer whereas others are more behind so more spaced out..know a centre round here had to stop for a month cause ran out or was a supply issue with one type.

Link to post
Share on other sites


Delta variant cases have increased by 240% in the UK in the last week, cases are doubling every 4.5 days in parts of England


Cases of the Delta variant of coronavirus first identified in India are estimated to be doubling every four and a half days in parts of England, new data suggests. Public Health England (PHE) said on 11 June that 42,323 cases of the Delta variant that originated in India have been confirmed in the UK. That’s up by 29,892 from last week.

Growth rates for Delta cases are high across all parts of the country, it added. Regional estimates for doubling time range from 4.5 days to 11.5 days.


PHE said the growth rate was shortest in the West Midlands and Yorkshire and the Humber. And it was longest in the East of England. In England 39,061 cases of the Delta variant of coronavirus have been confirmed. That’s along with 3,035 in Scotland, 184 in Wales, and 43 in Northern Ireland.

PHE said that more than 90% of new coronavirus (Covid-19) cases are now the Delta variant. Research suggests the variant is associated with an approximately 60% increased risk of household transmission compared with the Alpha (Kent) strain. PHE added that the increase in confirmed cases from 12,341 last week has been driven partly by a reduction in test turnaround times and a faster process for identifying cases of the variant.

Lib Dem MP Layla Moran, chairwoman of the All-Party Parliamentary Group (APPG) on Coronavirus, said:

These figures should set alarm bells ringing in Government as we approach… June 21. The Government must immediately explain to the public whether this exponential growth suggests the country is in line for a severe third wave, and if so what it is doing to prevent this.

As well as hospitalisations and deaths, ministers need to consider the debilitating impact of long Covid which is already affecting an estimated one million people.

Simply letting this highly contagious strain of the virus rip through unvaccinated younger people risks leaving more with long Covid and creating a ticking time bomb for our NHS.



As of 7 June, there have been 42 deaths in England of people who were confirmed as having the Delta variant and who died within 28 days of a positive test, according to PHE.

Of these, 23 were unvaccinated. Seven were more than 21 days after their first dose of vaccine, and 12 were more than 14 days after their second dose.



The figures also showed that two thirds of the 1,234 people who attended A&E in England between 1 February and 7 June, and who were confirmed as having the Delta variant, were unvaccinated.

A total of 220 (18%) were more than 21 days after their first dose of vaccine. And 83 (7%) were more than 14 days after their second dose, PHE added.

Of the 383 cases where attendance at A&E resulted in an overnight admission, 251 (66%) were unvaccinated. Meanwhile 66 (17%) were more than 21 days after their first dose of vaccine, and 42 (11%) were more than 14 days after their second.

Dr Jenny Harries, chief executive of the UK Health Security Agency, said:

With numbers of Delta variant cases on the rise across the country, vaccination is our best defence.

If you are eligible, we urge you to come forward and be vaccinated.

Remember that two doses provide significantly more protection than a single dose. However, while vaccination reduces the risk of severe disease, it does not eliminate it. With data showing that Delta is significantly more transmissible than Alpha, it is just as important as ever to follow public health advice, which has not changed.

Get vaccinated, work from home where you can and remember ‘hands, face, space, fresh air’ at all times.

These measures work, and they save lives.


HEALTH Coronavirus
Link to post
Share on other sites

A big thumbs up to the hospital in America who've suspended all staff who've refused to have the jab. Should have gone a step further and told them  they'll all be sacked if they do not make an appointment to have it.

It's time all governments around the world stepped up and do the difficult, unpopular,  but right thing to do in making it compulsory for all their citizens to have the jab and then introduce the covid passport. 

After all, we brought in drink driving laws to protect lives. Crash helmets, smoking indoors, speed limits on roads, drug laws. All restrictive on what people can do, but the right things to do all the same.

Once everyone has had the jab, then everyone will accept that everything that can be done has been done and it'll then be time to let everyone get on with their lives and accept the sad loss of lives the way they do with other illnesses.




Link to post
Share on other sites

High Hopes for Johnson & Johnson’s Covid Vaccine Have Fizzled in the U.S.

Production problems and a brief pause on its use kept the one-dose vaccine from becoming the game changer that health officials across the country believed it would be.


Cesar Gonzalez receiving his first dose of the Pfizer vaccine in LaPlace, La., on Thursday. Mr. Gonzalez traveled from Honduras to get vaccinated, but chose the Pfizer vaccine over Johnson & Johnson when both were offered.


WASHINGTON — When Johnson & Johnson’s single-dose coronavirus vaccine was authorized for emergency use in late February, it was seen as a breakthrough for reaching vulnerable and isolated Americans, a crucial alternative to vaccines that require two shots weeks apart and fussier storage. It was soon popular on college campuses, in door-to-door campaigns and with harder-to-reach communities that often struggle with access to health care.

But with only 11.8 million doses administered in the United States so far — less than 4 percent of the total — the “one and done” vaccine has fallen flat. States have warned for weeks that they may not find recipients for millions of doses that will soon expire, partly because the vaccine’s appeal dropped after it was linked to a rare but serious blood-clotting disorder and injections were paused for 10 days in April.

The vaccine took another hit last week, when regulators told Johnson & Johnson that it should throw out tens of millions of additional doses produced at a plant in Baltimore because they might be contaminated. The diminished supply and enthusiasm for the shot mean that its role in the United States is fading fast, even though millions of Americans have yet to be vaccinated.

“It’s just not what I think anybody would have hoped it would be when it came out,” said Dave Baden, the chief financial officer of the Oregon Health Authority.

Health officials in a number of other states presented a similarly discouraging picture. The pause on the Johnson & Johnson vaccine, they said, effectively kicked it aside for good; only about 3.5 million doses have been used since the pause was lifted on April 23. Kim Deti, a spokeswoman for the Wyoming Health Department, said the graph of uptake in her state told the vaccine’s story: a significant climb in the early weeks of its rollout, followed by a plateau that began around the pause.

State officials had initially hoped the Johnson & Johnson shot would be a workhorse: a versatile, easy-to-store tool they could stockpile at mass vaccination sites, quickly reaching thousands of people they would not need to track down for a second dose. But after demand dropped, their goals grew more modest.

It is being used in a smaller-bore fashion this week at the Fiesta festival in San Antonio, the College World Series in Omaha, a Juneteenth celebration in Johnstown, Pa., and an aquarium in Long Beach, Calif. At a food bank in Reno, Nev., 12 doses of the Johnson & Johnson vaccine were administered on Thursday, said Jocelyn Lantrip, the director of marketing and communications for the Food Bank of Northern Nevada.

Between the small number of doses distributed and the lack of interest in them, public health experts say, the United States missed a critical opportunity to address health disparities with a vaccine that should have been ideal for reaching vulnerable populations. Dr. Chip Riggins, a regional medical director who oversees vaccine events in south central Louisiana, said that few organizers requested the shot anymore, even in a state with one of the lowest vaccination rates in the country.

“In the early days of J&J, working with the African American community and the churches, the faith community here, it was a very, very popular option,” Dr. Riggins said. “It pains me that it isn’t being accepted like it was before the pause.”

Dr. José R. Romero, the Arkansas health secretary, called the shot’s fast decline a “lost opportunity” for reaching the vulnerable in his state.

“This is a vaccine that was very well-suited for populations where we have problems getting into,” he said. “We’re now at the point where it’s five people or three people; it doesn’t matter, we’ll open a vial.”

Dr. Riggins said he had limited success in recent months sending the vaccine to churches, casinos and even gas stations, including one in LaPlace, La., where organizers offered the shot on Thursday. An international crew on a ship was elated to receive their shots last weekend, Dr. Riggins said. But not being able to fully protect more people with just a single dose, he added, was hindering the state’s progress.

Johnson & Johnson’s decline in the United States has dovetailed with decreasing demand for Covid vaccines overall. Nearly 30 million doses of the Pfizer-BioNTech vaccine are sitting unused, as are about 25 million of Moderna’s. But a total of 135 million people have been fully immunized with those vaccines, 11 times more than with Johnson & Johnson’s. The two-dose vaccines have a higher efficacy rate overall — roughly 95 percent versus 72 percent for Johnson & Johnson’s — but studies showed that all three were highly effective at preventing hospitalization and death.

Alex Gorsky, Johnson & Johnson’s chief executive, said last week that he was still hopeful that the vaccine, which has been used in 26 countries so far, would help contain the pandemic overseas. The company has promised up to 400 million doses to the African Union. Separately, Covax, the global vaccine-sharing program, is supposed to receive hundreds of millions of doses.

“We still believe that this is going to be a very important tool in the overall armamentarium,” Mr. Gorsky said at an event hosted by The Wall Street Journal.

But manufacturing problems at a factory in Baltimore run by Emergent BioSolutions, Johnson & Johnson’s subcontractor, have had serious consequences for the vaccine. Because of a major production mishap that resulted in a two-month shutdown in operations, Johnson & Johnson has essentially been forced to sit out the brunt of the pandemic in the United States while Pfizer and Moderna, the other federally authorized vaccine makers, provided almost all the nation’s vaccine stock.

Johnson & Johnson has had to throw out the equivalent of 75 million doses, and the regulatory authorities in Canada, South Africa and the European Union also decided to pull back millions more doses made at the Baltimore plant. The company has been able to deliver less than half of the 100 million doses it promised the federal government by the end of this month.

Dr. Anne Zink, Alaska’s chief medical officer, said that in her state, Johnson & Johnson’s shot had become a victim of its own timing. By late February, when it was authorized by the Food and Drug Administration, Alaska had figured out how to get two-dose vaccines to remote areas, leaving the one-shot regimen less crucial than she had initially imagined.

Dr. Clay Marsh, West Virginia’s Covid-19 czar, said that the pause and Johnson & Johnson’s later authorization — more than two months after Pfizer’s and Moderna’s — deprived it of a “halo effect.” By the time West Virginia had an ample supply of all three vaccines, he said, “people started to get this concept that maybe there’s something better about being immunized with Pfizer and Moderna.”

The Johnson & Johnson shot had also suffered from a “social network effect,” said Andrew C. Anderson, a professor of public health at Tulane University who researches vaccine hesitancy. Most Americans who were inoculated in the early months of the vaccine campaign received Moderna and Pfizer shots, and so their friends and family were less likely to deviate and accept a different brand.

In Louisiana, hospitals in the New Orleans area have started offering the Johnson & Johnson shot to people on their way out of the emergency room; the thinking is that people will be more likely to accept the vaccine when a doctor who has treated them asks them to take it. And in Arkansas, where only a third of the population is fully vaccinated, state officials are offering Johnson & Johnson doses to agriculture, manufacturing, wastewater and poultry workers, with gift certificates for hunting and fishing licenses as a reward.

“I don’t think that the book on J&J is closed,” said Dr. Joseph Kanter, Louisiana’s top health official. “It’s just not going to be a game changer.”

In West Virginia, officials are now hoping to use up some 20,000 doses of the shot at summer fairs and festivals and in parks, Dr. Marsh said. And in Oregon, Mr. Baden, the state health authority official, said that providers were working to exhaust about 150,000 doses in correctional facilities and higher-throughput sites in Portland. The sharp drop in interest, he said, was “tragic.”

Onisis Stefas, the chief pharmacy officer at Northwell Health, New York State’s largest health care provider, said he was still working through the system’s original allocation of Johnson & Johnson from March — a sign that demand had shriveled long ago. Doctors’ offices have asked for as few as 10 doses at a time instead of the pack of 50 the vaccine typically comes in.

In Michigan, where more than 200,000 Johnson & Johnson doses sit unused, officials are racing to redistribute the vaccine to high-volume sites in hopes of administering them before they expire.

“It’s just kind of one after another negative news about the vaccine,” said Dr. Joneigh S. Khaldun, the chief medical executive in the state.

Link to post
Share on other sites

Out of control

If Peru was the size, population-wise, of the United States, they would now be closing in on 2 MILLION deaths.

To date, the official GLOBAL death count is around 3.9 million.

This chart is listed by highest death rate per million pops.


Link to post
Share on other sites

Vaccine Failings: The European Commission and AstraZeneca


In the messy, underhanded world of global health responses to COVID-19 it was only appropriate that lawyers should find themselves enriched on respective sides of a dispute about vaccine supply.  The pharmaceutical giant AstraZeneca has been getting a good deal of bad press, with its COVID vaccines seen to be a riskier proposition, notably to younger adults, than those of its rivals.  But the matter of rare blood clotting was less a bother to one of the company’s main customers – the European Union – than its failure to be timely and forthcoming with the number of contracted doses.

In January, AstraZeneca announced that it would not be able to deliver the promised doses on time as outlined in their August 2020 contact with the EU.  On March 19, with no discernable change, the European Commission commenced a dispute resolution process with the company.  As the Commission explained, the company’s failure “to develop a credible strategy to ensure compliance with its contractual commitment” left it “no other choice than to start legal proceedings.”

First came the application for an emergency injunction to convince the court that the deliveries be made to the countries in need as a matter of urgency.  The second part of the legal process entailed the Commission’s pursuit of the case on its merits in terms of mutual rights and obligations as understood by the contract.

AstraZeneca, for its part, submitted that it had fully complied in its agreement with the EU, arguing that it was only obliged to make “reasonable best efforts” to meet EU orders.  As with all such efforts, some run afoul of logistics and planning.  Supply problems could be explained by tardy vaccine production at the company plant in Belgium. While AstraZeneca accepted the point that the agreement permitted the option of supplying the bloc from UK sites, this would only be done once the UK had adequate supplies.

Depending on how you look at it, both sides could limp away with some consolation from the June 18 ruling of the Belgian court of first instance. The Brussels-based institution ordered AstraZeneca to deliver 80.2 million doses over a number of dates till September 27.  The doses are to come in a series of instalments, with 30 million of them already delivered at the end of the first quarter of 2021.  15 million is slated for delivery by July 26; 20 million by August 23; and 15 million by September 27.  Failing to do so would lead the company to incur €10 per undelivered dose per day.

The Commission was blunt in reviewing the court’s ruling.  “AstraZeneca grossly and intentionally breached the agreement with the EU.”  Commission President Ursula von der Leyen claimed it showed “clear recognition that our Advance Purchase Agreements have a sound legal basis.”  Such a view papered over the Commission’s lamentable negotiating efforts with AstraZeneca which had led to granting the company substantive legroom in discharging its obligations in the first place.

The Commission was triumphant in quoting the court’s ruling that “primate facie, the delays of the vaccination may have damaging consequences on individual freedoms of the EU citizens and, as a consequence, on the economic life of the EU and Member States.” It followed that this was “sufficiently serious to justify an immediate decision on the number of doses of vaccine that AstraZeneca had to deliver to the EU”.

The judgment also found that AstraZeneca had breached the agreement by “intentionally [choosing] not to use the means at its disposal to manufacture and deliver the vaccines”.  In prioritising the UK over the EU, the company “apparently – deliberately breached its contractual warranty, contained in Article 13.1(a) of the APA”.

This did not seem to bother to representatives of AZ, who noted that, “All other measures sought by the European Commission have been dismissed, and in particular the Court found that the European Commission has no exclusivity or right of priority over all other contracting parties”.  As the company has already dispensed with 70 million doses and has plans to deliver a further 10 million in good time, it is unlikely to face the penalty.  “The court case would have absolutely no impact and no change in terms of how fast we will get the doses of vaccine into the arms of EU citizens,” claimed a company spokesperson.

In a statement, the company also pointed out that the court “acknowledged that the difficulties experienced by AstraZeneca in this unprecedented situation had a substantial impact on the delay.”  The self-praise was quick in coming, which was understandable given the Commission’s failure in forcing the company to speed up doses or face penalties for previous breaches.  The supply of its vaccine was “estimated to have helped save tens of thousands of lives and to have significantly reduced hospitalisations.”  Craftily avoiding its own failings, the company urged that we look at the “Real World Evidence” which had “consistently shown a greater than 90% reduction in severe disease and hospitalisations caused by COVID-19”.  Effectiveness against the new Delta variant, measured at 92%, was also to be lauded.

The company also had every reason to be delighted about one crucial part of the judgment.  The lawyers for the Commission had not convinced the court to order AstraZeneca to deliver 120 million vaccine doses to the bloc by the end of June.  By the end of September, it was hoped that 300 million doses would have been delivered.

The entire exercise, then, seemed one of fatuous waste.  But not for the Commission’s lawyers, who insisted that the litigation pushed AstraZeneca along.  The company “has indeed anticipated that [it] would be condemned in the judgment, and has already delivered approximately 40 million doses in the period between end [of] March and now approximately.”  At best, this would have to count as an adventurous reading.

Link to post
Share on other sites


Huffman Town Hall Disrupted by Angry Anti-Vaxxers



In early June, Rep. Jared Huffman invited 100 constituents to register online to attend his first in-person town hall since the pandemic struck. Attendees were told to wear face masks and bring proof of vaccination to enter the San Rafael Community Center on Tuesday evening. Chairs were spaced six feet apart. “Large signs” and “banners” were declared verboten. Questions for Huffman were to be submitted online or on written forms prior to the show.

The town hall was a carefully planned effort to control not only the possibility of Covid infection, but the content of questions and the media presence. Shortly before the event, Huffman aides barred a television reporter from EnviroNews from entering, according to EnviroNews. They allowed a cameraman from Fox News KTVU to enter, however. 

This reporter had scored a seat online, and submitted a question asking Huffman to explain why he has banked more campaign funds from weapons manufacturers and agribusiness corporations than from environmental groups. But half of the spaced seats were empty and most of the attendees appeared to be eligible for Medicare. It looked to be a dull event.

Huffman’s effort to control the venue backfired in a big way when minutes after the meeting commenced about 200 enraged, shouting anti-vaccination protestors stormed into the room. They were mask-free, some wore buttons proclaiming unvaccinated status. Flags included the Stars & Stripes, and banners stating, “Don’t Tread on Me” and “Fuck Joe Biden”.

Jared Huffman town hall - June 8, 2021

Placards announced, “Marin Voters Against Vaccine Segregation,” “No Medical Apartheid,” “My Body, My Choice,” “Jab Mandate is Fascist,” “Vax Passports Illegally Discriminate,” “Freedom of Movement is a Human Right,” “Huffman, brought to you by BioMarin.”

After the anti-Vaxxers took the hall with putsch-like fervor, about a dozen people who had stood outside the center with signs protesting Huffman’s support for the culling of Tule elk at Point Reyes National Seashore edged into the hall. Wearing masks, the elk-supporters took seats, quietly, obviously astonished that they were inside, especially with large placards criticizing Huffman’s stance on the elk.

The politically adrenalized crowd flowed crazily around the room. A protestor jumped on the stage and sat down in front of Huffman waving a sign proclaiming, “All the ferrets died.”

Huffman did not call on the police, even though a squad was staged a few blocks away. He told people who were wary of getting Covid from what was just transformed into a probable super-spreader event, that they might want to exit. And then he gamely proceeded to conduct his town hall, which was streamed on Facebook. The congressman methodically answered a series of preselected questions, (which, sadly, did not include this reporter’s campaign fundraising query).

Despite the chaos, Huffman waxed professorial, seeming to delight in relaying the technical details of his legislative efforts to his few, seated, mask-wearing supporters. But faced with unremittent and loud chattering, chanting, and outbreaks of booing, the congressman paused to tell the crowd, which appeared to be local to Marin County, that they were “disrespectful of democracy, the law, and science.” They jeered.

At one point the “All the Ferrets died” protester tried to rip off the mask of an elderly man, but stopped when Huffman called her out. There were no placards or flags bearing the Trump logo, but as the meeting progressed it became clear that most of the anti-vaxxers were fervent supporters of the disgraced, white supremacist, electorally-defeated ex-president, who transformed denial of Covid-19 into a test of political fealty and the Republican Party into a fascistic mob unmoored from empirical reality and human decency. But we digress.

After Huffman criticized the U.S. Senate’s refusal to formally investigate the Jan. 6 insurrection with a commission, sections of the crowd booed, yelling, “Biden is an illegitimate president” and “no segregation” and “we want the filibuster.”

In a hallucinatory moment, a smiling woman shepherded several children wearing blue-tinged fairy wings and bearing anti-Vax signs in a march around the room to much applause.


As Huffman doggedly used the power of his microphone to explain his stances on the political issues of the day, the crowd, as if it shared an animalistic mind, repeatedly chimed in with its views. It opposed peace with Iran, universal Medicare, taxing the super rich. A snarling murmur of discontent roiled through the room as Huffman praised Biden’s diplomatic efforts in the Middle East. The masked elk supporters, however, cheered that effort, and Huffman thanked them for being polite. At which point the friends of the Tule elk began chanting pro-elk slogans and jumping up and down trying to ask more questions.

The hormonally-charged crowd calmed a bit when Huffman announced obtaining a total of $24 million to extend the SMART train to Healdsburg and to fix local infrastructure and to prevent wildfires with improved forest management. There were no snarls and chants when he spoke of improving the Postal Service. But when he noted that the population of California is growing, the crowd booed madly, presumably supposing that the growth is not of white middle class people such as themselves, but of Latino immigrants from Venezuela or Mars.


In fact, there was not a brown or black face to be seen in the anti-Vaxxer throng. Outside the center, however, a young woman wearing a Black Lives Matter shirt, held a singularly distinctive placard. One side noted that “we are standing on land stolen from the Miwok people”. The other side asked people to wear masks, because Covid is killing her people. When I photographed this brave person, a white woman accosted me with her suddenly realized grievance, demanding, “Why are you only taking pictures of her?”

As the town hall wound down, the anti-vaxxers gathered outside for a conspiratorial talk about how scores of ferrets injected with Covid vaccines have died from the treatment, which is not true. And then, satisfied with the pseudo scientific foundations of their cause, the mask-less mass marched through downtown San Raphael waving their cursing flags, chanting incoherently about the greatest hoax in the history of humankind.


Link to post
Share on other sites
29 minutes ago, NikkiCFC said:

Why so much cases in UK? After heavy vaccination?

The Delta variant.

Link to post
Share on other sites

New ‘Lambda’ South American Covid variant discovered in the UK




A further 514 people were admitted to hospital in England with Covid-19 in the week up to June 21. Of these, 304 were unvaccinated.


do the maths

40% of those with COVID (all strains, not just Lambda) so bad they had to be hospitalised WERE VACCINATED




Lambda is likely to be a ripper (fair chance it's worse than Delta)

Lambda (WHO label)


14-Jun-2021 (date named)

Look at poor Peru's death rate now, it is extraordinary how high it is (by far highest in the world) and how quickly it has all happened

if Peru was, population-wise, the size of the US, it would be close to having 2 million dead already




Link to post
Share on other sites



Finally after almost year and a half we are back with normal life! I was missing so much festivals and raves... Cant wait next week!

Not the greatest lineup but cant complain after nothing since 2019. 

Edited by NikkiCFC
Link to post
Share on other sites

The pandemic, driven by new variants, is surging in many parts of the world.


Medical workers removing a man last week from an emergency tent erected to accommodate a surge of Covid patients at Cengkareng Regional General Hospital in Jakarta, Indonesia.

The nightmare is returning.

In Indonesia, grave diggers are working into the night, as oxygen and vaccines are in short supply. In Europe, countries are slamming their doors shut once again, with quarantines and travel bans. In Bangladesh, urban garment workers fleeing an impending lockdown are almost assuredly seeding another coronavirus surge in their impoverished home villages.

And in countries like South Korea and Israel that seemed to have largely vanquished the virus, new clusters of disease have proliferated. Chinese health officials announced on Monday that they would build a giant quarantine center with up to 5,000 rooms to hold international travelers. Australia has ordered millions to stay at home.

A year and a half since it began racing across the globe with exponential efficiency, the pandemic is on the rise again in vast stretches of the world, driven largely by the new variants, particularly the highly contagious Delta variant first identified in India. From Africa to Asia, countries are suffering from record Covid-19 caseloads and deaths, even as wealthier nations with high vaccination rates have let their guard down, dispensing with mask mandates and reveling in life edging back toward normalcy.

Scientists believe the Delta variant may be twice as transmissible as the original coronavirus, and its potential to infect some partially vaccinated people has alarmed public health officials. Unvaccinated populations, whether in India or Indiana, may serve as incubators of new variants that could evolve in surprising and dangerous ways, with Delta giving rise to what Indian researchers are calling Delta Plus. There are also the Gamma and Lambda variants.

“We’re in a race against the spread of the virus variants,” said Professor Kim Woo-joo, an infectious disease specialist at Korea University Guro Hospital in Seoul.

Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Recently Browsing   0 members

    No registered users viewing this page.

  • Create New...